Works matching DE "VETERINARY therapeutics"

Results: 2134

Editorial: Bacteriophages, prophages, and their products: regulating bacterial populations.

Published in:

Frontiers in Microbiology, 2025, p. 1, doi. 10.3389/fmicb.2025.1628912

By:

Maciejewska, Barbara;
Dorotkiewicz-Jach, Agata;
Drulis-Kawa, Zuzanna;
López-Leal, Gamaliel

Publication type:

Article

Point d'actualité sur les traitements dermatologiques.

Published in:

2025

By:

Cadiergues, Marie-Christine

Publication type:

Editorial

The Chemical Analysis of Wild Thyme Variability for the Enhanced Production of Bioactive Compounds and Agro-Ecosystem Sustainability in the Mountains of Pistoia (Italy).

Published in:

Sustainability (2071-1050), 2025, v. 17, n. 11, p. 5073, doi. 10.3390/su17115073

By:

Santini, Costanza;
Bonetti, Daniele;
Della Maggiora, Lorenzo;
Tarraf, Waed;
Menicucci, Felicia;
Ieri, Francesca;
Crisci, Alfonso;
Cencetti, Gabriele;
Ienco, Andrea;
Palagano, Eleonora

Publication type:

Article

Metabolomics analysis of differential metabolites between wild gallnuts and cultivated gallnuts.

Published in:

Feed Research, 2025, v. 48, n. 7, p. 79, doi. 10.13557/j.cnki.issn1002-2813.2025.07.015

By:

LI Zhihui;
ZHANG Fulin;
GUAN Lifei;
XIONG Wei;
LI Renjun

Publication type:

Article

Pharmacokinetic Characteristics of a Single Cannabidiol Dose in Oil and Treat Forms and Health Impacts After 30 Days of Administration in Dogs.

Published in:

Animals (2076-2615), 2025, v. 15, n. 10, p. 1470, doi. 10.3390/ani15101470

By:

Kamutchat, Phattharakan;
Limsuwan, Sasithorn;
Leewichit, Nattaya;
Tansakul, Natthasit

Publication type:

Article

Antibiotic prophylaxis in veterinary cancer chemotherapy: A review and recommendations.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 3, p. 301, doi. 10.1111/vco.12406

By:

Bisson, J. L.;
Argyle, D. J.;
Argyle, S. A.

Publication type:

Article

Prognostic significance of clinical presentation, induction and rescue treatment in 42 cases of canine centroblastic diffuse large B‐cell multicentric lymphoma in the United Kingdom.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 2, p. 276, doi. 10.1111/vco.12378

By:

Davies, O.;
Szladovits, B.;
Polton, G.;
Garden, O. A.;
Leo, C.;
Lara‐Garcia, A.

Publication type:

Article

Preliminary investigation of blood concentrations of insulin‐like growth factor, insulin, lactate and β‐hydroxybutyrate in dogs with lymphoma as compared with matched controls.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 2, p. 262, doi. 10.1111/vco.12376

By:

McQuown, B.;
Burgess, K. E.;
Heinze, C. R.

Publication type:

Article

A retrospective review of acute myeloid leukaemia in 35 dogs diagnosed by a combination of morphologic findings, flow cytometric immunophenotyping and cytochemical staining results (2007‐2015).

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 2, p. 268, doi. 10.1111/vco.12377

By:

Davis, L. L.;
Hume, K. R.;
Stokol, T.

Publication type:

Article

Novel hyperthermia applicator system allows adaptive treatment planning: Preliminary clinical results in tumour‐bearing animals.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 2, p. 202, doi. 10.1111/vco.12340

By:

Dressel, S.;
Gosselin, M.‐C.;
Capstick, M. H.;
Carrasco, E.;
Weyland, M. S.;
Scheidegger, S.;
Neufeld, E.;
Kuster, N.;
Bodis, S.;
Rohrer Bley, C.

Publication type:

Article

Temozolomide alone or in combination with doxorubicin as a rescue agent in 37 cases of canine multicentric lymphoma.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 2, p. 194, doi. 10.1111/vco.12335

By:

Treggiari, E.;
Elliott, J. W.;
Baines, S. J.;
Blackwood, L.

Publication type:

Article

Oral melphalan for the treatment of relapsed canine lymphoma.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E123, doi. 10.1111/vco.12356

By:

Mastromauro, M. L.;
Suter, S. E.;
Hauck, M. L.;
Hess, P. R.

Publication type:

Article

Retrospective analysis of factors affecting clinical outcome following CHOP-based chemotherapy in dogs with primary nodal diffuse large B-cell lymphoma.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E159, doi. 10.1111/vco.12364

By:

Childress, M. O.;
Ramos-Vara, J. A.;
Ruple, A.

Publication type:

Article

Comparison of histologic margin status in low-grade cutaneous and subcutaneous canine mast cell tumours examined by radial and tangential sections.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. 125, doi. 10.1111/vco.12321

By:

Dores, C.B.;
Milovancev, M.;
Russell, D.S.

Publication type:

Article

LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. 108, doi. 10.1111/vco.12318

By:

Brown, P. M.;
Tzannes, S.;
Nguyen, S.;
White, J.;
Langova, V.

Publication type:

Article

A dose-escalation study of combretastatin A4-phosphate in healthy dogs.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E16, doi. 10.1111/vco.12327

By:

Abma, E.;
Smets, P.;
Daminet, S.;
Cornelis, I.;
De Clercq, K.;
Ni, Y.;
Vlerick, L.;
de Rooster, H.

Publication type:

Article

Canine brain tumours: a model for the human disease?

Published in:

Veterinary & Comparative Oncology, 2017, v. 15, n. 1, p. 252, doi. 10.1111/vco.12152

By:

Hicks, J.;
Platt, S.;
Kent, M.;
Haley, A.

Publication type:

Article

Utility of a multiple serum biomarker test to monitor remission status and relapse in dogs with lymphoma undergoing treatment with chemotherapy.

Published in:

Veterinary & Comparative Oncology, 2017, v. 15, n. 1, p. 6, doi. 10.1111/vco.12123

By:

Alexandrakis, I.;
Tuli, R.;
Ractliffe, S. C.;
Tappin, S. W.;
Foale, R. D.;
Roos, A.;
Slater, K. J.

Publication type:

Article

Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol.

Published in:

Veterinary & Comparative Oncology, 2016, v. 14, p. 147, doi. 10.1111/vco.12163

By:

Curran, K.;
Thamm, D. H.

Publication type:

Article

Safety of intrathecal administration of cytosine arabinoside and methotrexate in dogs and cats.

Published in:

Veterinary & Comparative Oncology, 2016, v. 14, n. 3, p. 331, doi. 10.1111/vco.12109

By:

Genoni, S.;
Palus, V.;
Eminaga, S.;
Cherubini, G. B.

Publication type:

Article

Investigation of the cytotoxic effect of flavopiridol in canine lymphoma cell lines.

Published in:

Veterinary & Comparative Oncology, 2016, v. 14, p. 95, doi. 10.1111/vco.12130

By:

Ema, Y.;
Igase, M.;
Takeda, Y.;
Yanase, T.;
Umeki, S.;
Hiraoka, H.;
Okuda, M.;
Mizuno, T.

Publication type:

Article

Canine and feline lymphoma: challenges and opportunities for creating a paradigm shift.

Published in:

2016

By:

Argyle, D. J.;
Pecceu, E.

Publication type:

Editorial

Patient characteristics, histopathological findings and outcome in 97 cats with extranodal subcutaneous lymphoma (2007-2011).

Published in:

Veterinary & Comparative Oncology, 2016, v. 14, p. 8, doi. 10.1111/vco.12081

By:

Meichner, K.;
von Bomhard, W.

Publication type:

Article

Treatment of feline lymphoma using a 12-week, maintenance-free combination chemotherapy protocol in 26 cats.

Published in:

Veterinary & Comparative Oncology, 2016, v. 14, p. 21, doi. 10.1111/vco.12082

By:

Limmer, S.;
Eberle, N.;
Nerschbach, V.;
Nolte, I.;
Betz, D.

Publication type:

Article

Masitinib monotherapy in canine epitheliotropic lymphoma.

Published in:

Veterinary & Comparative Oncology, 2016, v. 14, p. 127, doi. 10.1111/vco.12157

By:

Holtermann, N.;
Kiupel, M.;
Kessler, M.;
Teske, E.;
Betz, D.;
Hirschberger, J.

Publication type:

Article

Criteria for designation of clinical substage in canine lymphoma: a survey of veterinary oncologists.

Published in:

Veterinary & Comparative Oncology, 2016, v. 14, p. 32, doi. 10.1111/vco.12086

By:

Barber, L. G.;
Weishaar, K. M.

Publication type:

Article

Treatment of feline intermediate- to high-grade lymphoma with a modified university of Wisconsin-Madison protocol: 119 cases (2004-2012).

Published in:

Veterinary & Comparative Oncology, 2016, v. 14, p. 136, doi. 10.1111/vco.12158

By:

Collette, S. A.;
Allstadt, S. D.;
Chon, E. M.;
Vernau, W.;
Smith, A. N.;
Garrett, L. D.;
Choy, K.;
Rebhun, R. B.;
Rodriguez, C. O.;
Skorupski, K. A.

Publication type:

Article

The current state and a perspective towards the future of osteosarcoma in dogs.

Published in:

2016

By:

Khanna, C.

Publication type:

Editorial

Neoadjuvant and adjuvant chemotherapy combined with anatomical resection of feline injection-site sarcoma: results in 21 cats.

Published in:

Veterinary & Comparative Oncology, 2016, v. 14, n. 2, p. 147, doi. 10.1111/vco.12083

By:

Bray, J.;
Polton, G.

Publication type:

Article

Ocular manifestation of lymphoma in newly diagnosed cats.

Published in:

Veterinary & Comparative Oncology, 2016, v. 14, n. 1, p. 58, doi. 10.1111/vco.12061

By:

Nerschbach, V.;
Eule, J. C.;
Eberle, N.;
Höinghaus, R.;
Betz, D.

Publication type:

Article

Novel acyclic nucleotide analogues GS-343074 and GS-424044 demonstrate antiproliferative and pro-apoptotic activity in canine neoplastic cell lines.

Published in:

Veterinary & Comparative Oncology, 2015, v. 13, n. 3, p. 246, doi. 10.1111/vco.12038

By:

Lawrence, J. A.;
Huelsmeyer, M. K.;
Thamm, D. H.;
Tumas, D. B.;
Birkus, G.;
Kurzman, I.;
Vail, D. M.

Publication type:

Article

Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).

Published in:

Veterinary & Comparative Oncology, 2015, v. 13, n. 3, p. 267, doi. 10.1111/vco.12042

By:

Lejeune, A.;
Skorupski, K.;
Frazier, S.;
Vanhaezebrouck, I.;
Rebhun, R. B.;
Reilly, C. M.;
Rodriguez, C. O.

Publication type:

Article

Prolactin - to be reconsidered in canine mammary tumourigenesis?

Published in:

Veterinary & Comparative Oncology, 2014, v. 12, n. 2, p. 93, doi. 10.1111/j.1476-5829.2012.00337.x

By:

Michel, E.;
Rohrer Bley, C.;
Kowalewski, M. P.;
Feldmann, S. K.;
Reichler, I. M.

Publication type:

Article

Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer.

Published in:

Veterinary & Comparative Oncology, 2014, v. 12, n. 2, p. 160, doi. 10.1111/j.1476-5829.2012.00350.x

By:

Waite, A.;
Balkman, C.;
Bailey, D.;
Kiselow, M.;
Flory, A.;
Beaulieu, B. B.;
Lewis, L. D.;
McEntee, M.

Publication type:

Article

Epirubicin as part of a multi-agent chemotherapy protocol for canine lymphoma.

Published in:

Veterinary & Comparative Oncology, 2013, v. 11, n. 3, p. 185, doi. 10.1111/j.1476-5829.2011.00311.x

By:

Elliott, J. W.;
Cripps, P.;
Marrington, A. M.;
Grant, I. A.;
Blackwood, L.

Publication type:

Article

Fascin-1 expression in canine cutaneous and oral melanocytic tumours.

Published in:

Veterinary & Comparative Oncology, 2012, v. 10, n. 4, p. 303, doi. 10.1111/j.1476-5829.2011.00300.x

By:

Yamada, N.;
Mori, T.;
Murakami, M.;
Noguchi, S.;
Sakai, H.;
Akao, Y.;
Maruo, K.

Publication type:

Article

Nuclear morphometry in cytological specimens of canine ceruminous adenomas and carcinomas.

Published in:

Veterinary & Comparative Oncology, 2012, v. 10, n. 4, p. 246, doi. 10.1111/j.1476-5829.2011.00289.x

By:

Simeonov, R.

Publication type:

Article

Three-dimensional conformal versus non-graphic radiation treatment planning for apocrine gland adenocarcinoma of the anal sac in 18 dogs (2002-2007).

Published in:

Veterinary & Comparative Oncology, 2012, v. 10, n. 4, p. 237, doi. 10.1111/j.1476-5829.2011.00288.x

By:

Keyerleber, M. A.;
Gieger, T. L.;
Erb, H. N.;
Thompson, M. S.;
McEntee, M. C.

Publication type:

Article

Use of CD9 and CD61 for the characterization of AML-M7 by flow cytometry in a dog* Use of CD9 and CD61 for the characterization of AML-M7 by flow cytometry in a dog.

Published in:

Veterinary & Comparative Oncology, 2012, v. 10, n. 4, p. 312, doi. 10.1111/j.1476-5829.2011.00290.x

By:

Valentini, F.;
Tasca, S.;
Gavazza, A.;
Lubas, G.

Publication type:

Article

Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours.

Published in:

Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 194, doi. 10.1111/j.1476-5829.2011.00275.x

By:

London, C.;
Mathie, T.;
Stingle, N.;
Clifford, C.;
Haney, S.;
Klein, M. K.;
Beaver, L.;
Vickery, K.;
Vail, D. M.;
Hershey, B.;
Ettinger, S.;
Vaughan, A.;
Alvarez, F.;
Hillman, L.;
Kiselow, M.;
Thamm, D.;
Higginbotham, M. L.;
Gauthier, M.;
Krick, E.;
Phillips, B.

Publication type:

Article

European consensus document on mast cell tumours in dogs and cats.

Published in:

Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. e1, doi. 10.1111/j.1476-5829.2012.00341.x

By:

Blackwood, L.;
Murphy, S.;
Buracco, P.;
De Vos, J. P.;
De Fornel-Thibaud, P.;
Hirschberger, J.;
Kessler, M.;
Pastor, J.;
Ponce, F.;
Savary-Bataille, K.;
Argyle, D. J.

Publication type:

Article

Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib.

Published in:

Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 206, doi. 10.1111/j.1476-5829.2011.00292.x

By:

de Vos, J.;
Ramos Vega, S.;
Noorman, E.;
de Vos, P.

Publication type:

Article

Phosphotyrosine enrichment identifies focal adhesion kinase and other tyrosine kinases for targeting in canine hemangiosarcoma.

Published in:

Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 214, doi. 10.1111/j.1476-5829.2012.00325.x

By:

Marley, K.;
Maier, C. S.;
Helfand, S. C.

Publication type:

Article

In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell lines In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell lines*.

Published in:

Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 223, doi. 10.1111/j.1476-5829.2012.00335.x

By:

Lyles, S. E.;
Milner, R. J.;
Kow, K.;
Salute, M. E.

Publication type:

Article

Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study.

Published in:

Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 174, doi. 10.1111/j.1476-5829.2011.00261.x

By:

Robat, C.;
London, C.;
Bunting, L.;
McCartan, L.;
Stingle, N.;
Selting, K.;
Kurzman, I.;
Vail, D. M.

Publication type:

Article

Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study

Published in:

Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 184, doi. 10.1111/j.1476-5829.2011.00265.x

By:

Chon, E.;
McCartan, L.;
Kubicek, L. N.;
Vail, D. M.

Publication type:

Article

A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma.

Published in:

Veterinary & Comparative Oncology, 2011, v. 9, n. 4, p. 283, doi. 10.1111/j.1476-5829.2011.00266.x

By:

Teske, E.;
Rutteman, G. R.;
Kirpenstein, J.;
Hirschberger, J.

Publication type:

Article

Single-agent gemcitabine chemotherapy in dogs with hepatocellular carcinomas.

Published in:

Veterinary & Comparative Oncology, 2011, v. 9, n. 4, p. 260, doi. 10.1111/j.1476-5829.2011.00262.x

By:

Elpiner, A. K.;
Brodsky, E. M.;
Hazzah, T. N.;
Post, G. S.

Publication type:

Article

Detection of tumour necrosis factor-alpha in dogs with lymphoma.

Published in:

Veterinary & Comparative Oncology, 2011, v. 9, n. 4, p. 290, doi. 10.1111/j.1476-5829.2011.00267.x

By:

Hofer, J.;
DeFrancesco, T. C.;
Williams, L. E.

Publication type:

Article

Radiosensitivity and capacity for radiation-induced sublethal damage repair of canine transitional cell carcinoma (TCC) cell lines.

Published in:

Veterinary & Comparative Oncology, 2011, v. 9, n. 3, p. 232, doi. 10.1111/j.1476-5829.2010.00258.x

By:

Parfitt, S. L.;
Milner, R. J.;
Salute, M. E.;
Hintenlang, D. E.;
Farese, J. P.;
Bacon, N. J.;
Bova, F. J.;
Rajon, D. A.;
Lurie, D. M.

Publication type:

Article